The number of confirmed Ebola cases in the Democratic Republic of Congo has risen to 3,200, including 1,405 deaths, according to government data released on Sunday, highlighting the scale of an outbreak that continues to challenge health authorities and aid agencies.
As the outbreak grows, researchers in the United Kingdom have begun testing a new experimental vaccine that scientists hope could help combat the virus responsible for the latest wave of infections.
The first person in the world to receive the vaccine is Ed Hunt, a 37-year-old volunteer from the UK, who was inoculated in Oxford as part of an early-stage clinical trial.
Hunt said he decided to take part after following reports of the crisis in the Democratic Republic of Congo.
- Ed Hunt
He is the first of 50 healthy volunteers aged between 18 and 55 who will participate in the initial study.
The vaccine was developed by researchers at the University of Oxford using the same platform that was employed to create the Oxford-AstraZeneca Covid-19 vaccine.
Scientists say they produced the candidate vaccine in just eight weeks, drawing on decades of previous research into infectious diseases and vaccine development.
Professor Teresa Lambe, who leads the Oxford vaccine team, said the technology enabled researchers to respond quickly to the outbreak.
Researchers say the vaccine has been designed to protect against the Bundibugyo strain of Ebola, the variant linked to the current outbreak in the Democratic Republic of Congo.
While a licensed vaccine already exists for the Zaire strain of the virus, it does not provide protection against the Bundibugyo strain, creating an urgent need for new options.
The Oxford vaccine is the first of four Bundibugyo-targeted candidates currently in development to enter human testing.
The trial's first phase will focus on determining whether the vaccine is safe and capable of producing a strong immune response.
"We will not be giving anybody Ebola in this trial or any trial," Lambe said.
"The aim of the phase one clinical study is to look for the safety of the vaccine, and also to see if we're getting a strong immune response that could be protective against the Bundibugyo species of Ebola."
Researchers stress that the vaccine cannot cause Ebola infection.
Following the Oxford trial, scientists plan to launch a second small-scale study in Uganda before moving on to a larger efficacy trial in the Democratic Republic of Congo.
If the vaccine proves successful, it could be deployed rapidly. The Serum Institute of India has already manufactured 600,000 doses in preparation for potential future use.
For communities battling a growing outbreak and rising death toll, researchers hope the vaccine will become a key tool in controlling the spread of Ebola and preventing further loss of life.
A known Islamist suspected of driving a minivan into a crowd near a major LGBTQ Pride gathering in Berlin was shot dead during a police operation at a...
Ship traffic through the Bab el-Mandeb Strait fell to its lowest level in months on Sunday after Yemen's Houthi movement attacked Saudi oil facilities...
The chief executive of a Turkish defence company has said the United States has approved the export of GE F110 engines for Türkiye’s KAAN fighter j...
Iran will halt its own attacks as long as the United States maintains its pause on strikes, but Tehran remains sceptical of U.S. intentions, a senior Iranian source told on Sunday.
Ship traffic through the Bab el-Mandeb Strait fell to its lowest level in months on Sunday after Yemen's Houthi movement attacked Saudi oil facilities along the Red Sea coast, while vessel movements through the Strait of Hormuz also remained subdued despite a pause in U.S.-Iran tensions.
Kazakhstan's President Kassym-Jomart Tokayev called on Saturday for Russia and Ukraine to freeze the conflict and return to peace talks, saying a negotiated settlement remained possible despite the entrenched positions of both sides.
Marvel Studios used its return to San Diego Comic-Con to reveal several major projects, including a new Ghost Rider film starring Ryan Gosling and the long-awaited Black Panther 3.
A known Islamist suspected of driving a minivan into a crowd near a major LGBTQ Pride gathering in Berlin was shot dead during a police operation at an allotment garden complex, broadcaster RBB reported on Sunday.
A known Islamist suspected of driving a minivan into a crowd near a major LGBTQ Pride gathering in Berlin was shot dead during a police operation at an allotment garden complex, broadcaster RBB reported on Sunday.
Russian President Vladimir Putin has signed laws introducing stricter financial requirements for foreign workers, as Moscow continues to tighten migration controls affecting millions of labour migrants, particularly from Central Asia.
The 27 July edition of Daybreak covers a pause in fighting between the U.S. and Iran, the latest developments in Russia's war against Ukraine, and mass evacuations as wildfires continue to spread across France and Spain.
French President Emmanuel Macron convened an interministerial crisis meeting on 26 July as wildfires spread across southwest France, with flames advancing to within 15 kilometres of the city of Bordeaux.
The United Nations will choose its next secretary-general this summer, with António Guterres set to leave office after two terms. Several candidates have entered the race to become the UN’s 10th chief, but the selection process remains shaped by negotiations among major powers.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment